SCHEMBL25899385

SCHEMBL25899385

CCC(C)c1cccc(C(=O)OC(C)(C)c2ccncc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.42
▸ GAA P10253 3/20 0.42
▸ HDAC4 P56524 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40
▸ HDAC8 Q9BY41 1/20 0.40
▸ ROCK2 O75116 3/20 0.39
▸ MAPT P10636 3/20 0.38
▸ TP53 P04637 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ AGTR1 P30556 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ CYP17A1 P05093 1/20 0.38
▸ CYP19A1 P11511 1/20 0.38
▸ SLC7A5 Q01650 1/20 0.36
▸ ABCB1 P08183 1/20 0.36
▸ ABCG2 Q9UNQ0 1/20 0.36
▸ PARP1 P09874 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25899377 0.85 ALDH1A1 (0.43) ALDH1A1GAAMAPTTP53SMN1; SMN2
SCHEMBL13137698 0.82 SLC7A5 (0.51) ALDH1A1GAAHDAC4HDAC2HDAC8
SCHEMBL13137700 0.80 HDAC4 (0.46) ALDH1A1GAAHDAC4HDAC2HDAC8
SCHEMBL24512404 0.76 HDAC4 (0.53) ALDH1A1GAAHDAC4HDAC2HDAC8
SCHEMBL24511995 0.76 HDAC4 (0.53) ALDH1A1GAAHDAC4HDAC2HDAC8
SCHEMBL14062636 0.76 CYP17A1 (0.48) ALDH1A1MAPTNPC1RAB9ATDP1
SCHEMBL1787505 0.75 HDAC4 (0.51) ALDH1A1HDAC4HDAC2HDAC8RAB9A
SCHEMBL28346938 0.75 HDAC4 (0.51) ALDH1A1HDAC4HDAC2HDAC8RAB9A
SCHEMBL9742858 0.75 HDAC4 (0.51) ALDH1A1GAAHDAC4HDAC2HDAC8
SCHEMBL13704323 0.75 ALDH1A1 (0.48) ALDH1A1MAPTTP53SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11709427-B2 Positive resist composition and pattern forming process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-07-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11709427-B2 Positive resist composition and pattern forming process EWSR1, PARG, VIM ALDH1A1 3639/4885GAA 4771/4885HDAC4 1950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback